Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Åsa Makower"'
Autor:
Natalie M. Hendrikse, Anna Sandegren, Tommy Andersson, Jenny Blomqvist, Åsa Makower, Dominik Possner, Chao Su, Niklas Thalén, Agneta Tjernberg, Ulrica Westermark, Johan Rockberg, Stefan Svensson Gelius, Per-Olof Syrén, Erik Nordling
Publikováno v:
iScience, Vol 24, Iss 3, Pp 102154- (2021)
Summary: We show the successful application of ancestral sequence reconstruction to enhance the activity of iduronate-2-sulfatase (IDS), thereby increasing its therapeutic potential for the treatment of Hunter syndrome—a lysosomal storage disease c
Externí odkaz:
https://doaj.org/article/d39df5cce7224dbcaf4d0e1329c50468
Autor:
Susanne Gustavsson, Elisabet Ohlin Sjöström, Agneta Tjernberg, Juliette Janson, Ulrica Westermark, Tommy Andersson, Åsa Makower, Erik Arnelöf, Gudrun Andersson, Jan Svartengren, Carina Ekholm, Stefan Svensson Gelius
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 21, Iss , Pp - (2019)
Mucopolysaccharidosis type IIIA (MPS IIIA) is a lysosomal storage disorder (LSD) characterized by severe central nervous system (CNS) degeneration. The disease is caused by mutations in the SGSH gene coding for the lysosomal enzyme sulfamidase. Sulfa
Externí odkaz:
https://doaj.org/article/5c5925a40eaf4e558c81d318fcb0dd0e
Autor:
Åsa Makower, Susanne Gustavsson, Agneta Tjernberg, Stefan Svensson Gelius, Tommy Andersson, Juliette Janson, Erik Arnelöf, Per-Olof Edlund
Publikováno v:
Bioanalysis. 11:1389-1403
Aim: Accumulation of heparan sulfate (HS) is associated with the neurodegenerative disorder Mucopolysaccharidosis type IIIA (MPS IIIA). Here, we compare HS levels in brain and cerebrospinal fluid (CSF) of MPS IIIA mice after treatment with a chemical
Autor:
Åsa Makower, Anna Sandegren, Per-Olof Syrén, Stefan Svensson Gelius, Chao Su, Natalie M. Hendrikse, Dominik Possner, Agneta Tjernberg, Tommy Andersson, Niklas Thalén, Johan Rockberg, Jenny Blomqvist, Erik Nordling, Ulrica Westermark
Publikováno v:
iScience
iScience, Vol 24, Iss 3, Pp 102154-(2021)
iScience, Vol 24, Iss 3, Pp 102154-(2021)
Summary We show the successful application of ancestral sequence reconstruction to enhance the activity of iduronate-2-sulfatase (IDS), thereby increasing its therapeutic potential for the treatment of Hunter syndrome—a lysosomal storage disease ca
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 185
Host cell proteins (HCPs) in biotherapeutics can be identified by the use of enzymatic digestion and LC–MS/MS analysis. However, the major challenge is that HCPs are often present at very low levels in relation to the protein drug (low ppm-levels).